UK As New Global Base, Serum Institute Mulls Acquisition Or Greenfield Unit
£240m Investment Committed
After setting up a sales base in the UK, Serum Institute could consider an acquisition in Europe or investment in an Oxford facility as it ties up production for its multiple COVID-19 vaccines. Is Wockhardt’s Wrexham facility an option?